Loading... Please wait... Loading... Please wait...
ESTIMATED
03/12/2024
03/12/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q3 2024 | 0 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2024 | 0 | -$0.09 | -$0.09 | -$0.09 |
| Q1 2025 | 0 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2025 | 0 | -$0.08 | -$0.08 | -$0.08 |
Champions Oncology, Inc. last posted its earnings results on Tuesday, March 12th, 2024. The company reported $-0.19 earnings per share for the quarter, missing analysts' consensus estimates of $-0.06 by $0.13. The company had revenue of 12.02 M for the quarter and had revenue of 53.87 M for the year. Champions Oncology, Inc. has generated $0 earnings per share over the last year ($-0.39 diluted earnings per share) and currently has a price-to-earnings ratio of -7.06. Champions Oncology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 22nd, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 03/14/2024 | Q3 2024 | -$0.19 | $13.50 M | $12.02 M | 12/13/2023 | Q2 2024 | -$0.15 | $11.57 M | 09/13/2023 | Q1 2024 | -$0.10 | -$0.19 | -0.09 | $12.56 M | 07/24/2023 | Q4 2023 | -$0.19 | $12.84 M | $13.07 M | 03/16/2023 | Q3 2023 | -$0.18 | $13.13 M | $12.77 M | 12/13/2022 | Q2 2023 | -$0.00 | -$0.00 | -0 | $14.28 M | 09/12/2022 | Q1 2023 | -$0.02 | $13.75 M | 07/22/2022 | Q4 2022 | -$0.03 | $12.77 M | $12.88 M | 03/15/2022 | Q3 2022 | $0.03 | $0.06 | 0.04 | $13.03 M | $13.19 M | 12/13/2021 | Q2 2022 | $0.01 | $0.02 | 0.02 | $11.79 M | 09/13/2021 | Q1 2022 | -$0.00 | -$0.01 | -0.01 | $11.25 M | 07/26/2021 | Q4 2021 | -$0.04 | $10.03 M | $10.57 M | 03/15/2021 | Q3 2021 | $0.07 | $10.14 M | $10.81 M | 12/14/2020 | Q2 2021 | $0.01 | $0.00 | -0.01 | $10.12 M | 09/14/2020 | Q1 2021 | $0.02 | $0.01 | -0.01 | $9.55 M | 07/28/2020 | Q4 2020 | -$0.17 | $8.25 M | $8.75 M | 03/16/2020 | Q3 2020 | $0.03 | $9.01 M | $9.01 M | 12/16/2019 | Q2 2020 | $0.01 | $0.03 | 0.02 | $7.63 M | 09/16/2019 | Q1 2020 | -$0.02 | -$0.06 | -0.04 | $6.74 M | 07/29/2019 | Q4 2019 | -$0.02 | $7.71 M | $7.72 M |
|---|
A. Champions Oncology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 22nd, 2024 based off last year's report dates.
A. The conference call for Champions Oncology, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Champions Oncology, Inc.'s latest earnings report can be read online.
A. Champions Oncology, Inc. (NASDAQ:CSBR) has a recorded annual revenue of $53.87 M.
A. Champions Oncology, Inc. (NASDAQ:CSBR) has a recorded net income of $53.87 M. Champions Oncology, Inc. has generated $-0.39 earnings per share over the last four quarters.
A. Champions Oncology, Inc. (NASDAQ:CSBR) has a price-to-earnings ratio of -7.06 and price/earnings-to-growth ratio is -0.37.
